[HTML][HTML] Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis

M Yang, Y Mu, X Yu, D Gao, W Zhang, Y Li, J Liu… - Biomedicine & …, 2024 - Elsevier
During tumor development, the tumor itself must continuously generate new blood vessels to
meet their growth needs while also allowing for tumor invasion and metastasis. One of the …

The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy

N Gariballa, F Mohamed, S Badawi, BR Ali - Journal of Biomedical Science, 2024 - Springer
The endoplasmic reticulum (ER) employs stringent quality control mechanisms to ensure the
integrity of protein folding, allowing only properly folded, processed and assembled proteins …

An unusual cause of right heart dysfunction and high output heart failure in a young woman

N Ariza Ordoñez, A Pino Marín… - Journal of …, 2022 - mdpi.com
A 35-year-old female presented to our emergency department with clinical signs of acute
heart failure. Clinical workup identified severe right heart (RH) dilation and dysfunction with …

[HTML][HTML] Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia

L Ielasi, M Tonnini, F Piscaglia… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Hereditary hemorrhagic teleangiectasia (HHT), also known as Rendu-Osler-Weber
syndrome, is the most common cause of hepatic vascular malformations in adults. Different …

A Rare Association: Hereditary Hemorrhagic Telangiectasia with Liver Cirrhosis Causing Portal Hypertension

D Morales-Tovar, FD Martínez-Sánchez… - Case Reports in …, 2024 - Wiley Online Library
Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu–Osler–Weber
syndrome, is a vascular disorder of autosomal dominant etiology. The hallmark clinical …

Hereditary Hemorrhagic Telangiectasia in a Patient Undergoing Hemodialysis with Anticoagulants and Antiplatelets

E Otsuka, M Kitamura, K Sawase, M Nakamura… - Internal …, 2024 - jstage.jst.go.jp
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder that causes
abnormal blood vessel formation and bleeding. We herein report a 61-year-old woman with …

Recent Advances in Hereditary Hemorrhagic Telangiectasia Pathogenesis and Therapies

Y Alka, Z Shabani, JK Dhaliwal, A Schmidt, H Su - 2024 - preprints.org
Abstract Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu
syndrome, is a rare and inherited vascular disorder, characterized by the development of …

[HTML][HTML] Ischemic cholangitis: Lethal complication of Osler-Weber-Rendu disease

O Elmqaddem, H Koulali, A Zazour, M Nasiri… - Radiology Case …, 2024 - Elsevier
Abstract Osler-Weber-Rendu disease (OWRD), also known as hereditary haemorrhagic
telangiectasia (HHT), is an autosomal dominant genetic disorder characterised by …

[HTML][HTML] Multifocal Abscesses, Necrotizing Fasciitis, Iron Deficiency Anemia, and Hypophosphatemia Induced by Ferric Carboxymaltose Infusions: Report of a Case of …

LA Trevise, MPLV Pinto, G Hasselmann… - Cureus, 2023 - ncbi.nlm.nih.gov
Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal dominant vascular
dysplasia in which disrupted angiogenesis leads to increased formation of mucocutaneous …

La maladie de Rendu-Osler (télangiectasie hémorragique héréditaire)

A Parrot, M Barral, X Amiot, C Bachmeyer… - Revue des Maladies …, 2023 - Elsevier
Résumé La maladie de Rendu-Osler (MRO) est une maladie vasculaire du capillaire,
héréditaire autosomique dominante, rare, avec une prévalence de 1/5000. Elle est …